Hinge Health, Inc. (HNGE)

Hinge Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023
Net Income	31.67	-11.93	-108.14
Depreciation & Amortization	2.24	2.35	2.13
Other Amortization	36.24	33.51	23.84
Loss (Gain) From Sale of Investments	0.38	0.54	-10.76
Stock-Based Compensation	0.44	0.74	1.65
Provision & Write-off of Bad Debts	5.38	5.41	4.86
Other Operating Activities	4.32	4.88	13.11
Change in Accounts Receivable	-18.41	-1.34	-23.13
Change in Inventory	-2.84	0.61	10.57
Change in Accounts Payable	-3.18	-10.98	11.56
Change in Unearned Revenue	75.48	77.16	35.97
Change in Other Net Operating Assets	-45.13	-51.95	-25.56
Operating Cash Flow	86.59	49	-63.91
Capital Expenditures	-0.96	-1.04	-1.98
Sale (Purchase) of Intangibles	-2.62	-2.73	-2.64
Investment in Securities	-11.67	22.09	6.12
Investing Cash Flow	-19.25	18.31	1.5
Issuance of Common Stock	0.65	0.61	0.49
Other Financing Activities	1.2	-2.81	-3.49
Financing Cash Flow	1.84	-2.2	-3
Net Cash Flow	69.18	65.11	-65.41
Free Cash Flow	85.63	47.96	-65.89
Free Cash Flow Margin	19.84%	12.29%	-22.51%
Free Cash Flow Per Share	2.56	3.54	-5.06
Levered Free Cash Flow	-	73.18	-
Unlevered Free Cash Flow	-	73.18	-
Change in Net Working Capital	-	-55.62	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q